Zobrazeno 1 - 10
of 70
pro vyhledávání: '"C. de Bodinat"'
Publikováno v:
European Neuropsychopharmacology. 40:S186-S187
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fd26a16930f695480cea84165056b571
https://doi.org/10.1016/j.euroneuro.2020.09.244
https://doi.org/10.1016/j.euroneuro.2020.09.244
Publikováno v:
Journal of Affective Disorders
Journal of Affective Disorders, Elsevier, 2016, 199, pp. 6-12. ⟨10.1016/j.jad.2016.03.048⟩
Journal of Affective Disorders, 2016, 199, pp. 6-12. ⟨10.1016/j.jad.2016.03.048⟩
Journal of Affective Disorders, Elsevier, 2016, 199, pp. 6-12. ⟨10.1016/j.jad.2016.03.048⟩
Journal of Affective Disorders, 2016, 199, pp. 6-12. ⟨10.1016/j.jad.2016.03.048⟩
Background A double-blind, randomized, study was conducted in 29 centers in Romania to evaluate the effect of agomelatine 25–50 mg/day (n=144 patients) on general interest, overall clinical efficacy, and functionality in comparison with escitalopra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6e500dc06c8aeab79aa109e2deacd31
https://doi.org/10.1016/j.jad.2016.03.048
https://doi.org/10.1016/j.jad.2016.03.048
Publikováno v:
Journal of Affective Disorders. 221
Emotional blunting is regularly reported in depressed patients on antidepressant treatment but its actual frequency is poorly understood. We have previously used qualitative methods to develop an appropriate scale, the Oxford Questionnaire on the Emo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58a9f2163552b41ae542eef4ca429eaf
http://ora.ox.ac.uk/objects/uuid:
http://ora.ox.ac.uk/objects/uuid:
Autor:
F. Picarel-Blanchot, Sidney H. Kennedy, Reinhard Heun, A. Avedisova, A. Ahokas, Valérie Olivier, C. De Bodinat
Publikováno v:
European Neuropsychopharmacology. 29:S233-S234
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b17ff672d05ef36d34676eb881235675
https://doi.org/10.1016/j.euroneuro.2018.11.376
https://doi.org/10.1016/j.euroneuro.2018.11.376
Autor:
Beatrice Guardiola-Lemaitre, Carmen Muńoz, Philippe Delagrange, C De Bodinat, Elisabeth Mocaer, Mark Millan
Publikováno v:
British Journal of Pharmacology. 171:3604-3619
Agomelatine behaves both as a potent agonist at melatonin MT1 and MT2 receptors and as a neutral antagonist at 5-HT2C receptors. Accumulating evidence in a broad range of experimental procedures supports the notion that the psychotropic effects of ag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5cdee1fd06a1559951a7adac465c4f3a
https://doi.org/10.1111/bph.12720
https://doi.org/10.1111/bph.12720
Autor:
C. De Bodinat, T. Hall, Richard Emsley, Y.M. Mok, Marcus R. Munafò, U. Marx, E. Scott, A. Mcintyre, I. Reis De Oliveira, F. Picarel-Blanchot, Guy M. Goodwin, Emmanuelle Corruble, Valérie Olivier
Publikováno v:
European Neuropsychopharmacology. 27:S788-S789
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::07e33d3e9c74ce28d2d423e6b0ae7be4
https://doi.org/10.1016/s0924-977x(17)31434-7
https://doi.org/10.1016/s0924-977x(17)31434-7
Autor:
F. Picarel-Blanchot, A. Ahokas, Valérie Olivier, Livia Vavrusova, C. De Bodinat, Oleg S. Chaban, A. Avedisova, Dan J. Stein, Marek Jarema, Celine Gruget
Publikováno v:
European Neuropsychopharmacology. 26:S601-S602
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f74821dfe75c5c51f72c3dbdb9a22e17
https://doi.org/10.1016/s0924-977x(16)31678-9
https://doi.org/10.1016/s0924-977x(16)31678-9
Autor:
C. De Bodinat, Siegfried Kasper, F. Picarel-Blanchot, J. Landowski, U. Marx, Göran Hajak, Valérie Olivier
Publikováno v:
European Neuropsychopharmacology. 27:S849
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3351218c27fe7c43ddaa8d75a0044802
https://doi.org/10.1016/s0924-977x(17)31526-2
https://doi.org/10.1016/s0924-977x(17)31526-2
Publikováno v:
British journal of pharmacology. 171(15)
Agomelatine behaves both as a potent agonist at melatonin MT1 and MT2 receptors and as a neutral antagonist at 5-HT2C receptors. Accumulating evidence in a broad range of experimental procedures supports the notion that the psychotropic effects of ag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3af74d998f9688072825b1fb61371c94
https://pubmed.ncbi.nlm.nih.gov/24724693
https://pubmed.ncbi.nlm.nih.gov/24724693
Autor:
P. Dehelean, Reinhard Heun, F. Picarel-Blanchot, C. De Bodinat, A. Ahokas, Humberto Nicolini, R.M. Corral, J.M. Teixeira
Publikováno v:
European Neuropsychopharmacology. 24:S403-S404
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ac411871005771b47266d20ba6595662
https://doi.org/10.1016/s0924-977x(14)70643-1
https://doi.org/10.1016/s0924-977x(14)70643-1